ÂÜÀòÂÒÂ×

Milad Alucozai is a Co-Founder of Revalia Bio and the Wyss Institute at Harvard University, where Milad also co-hosts the Code to Cure Series. As a first investor and Board Member at Seqera Labs, Milad contributes to the company’s strategic direction. In addition, Milad serves as a Visiting Scientist and Senior Advisor at the Indiana Biosciences Research Institute and holds the position of Senior Advisor at the 16 Tech Innovation District. Milad's academic credentials include a role as a Visiting Scholar at Harvard University's Wyss Institute for Biologically Inspired Engineering and education from The Johns Hopkins University School of Medicine.